Antitope Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 121

Employees

  • Latest Deal Type
  • Grant

  • Financing Rounds
  • 2

Antitope General Information

Description

Provider of the bio pharmaceuticals services. The company provides the technologies for immunogenicity prediction, antibody humanization and engineering of therapeutic proteins.

Contact Information

Formerly Known As
Antitope Limited
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Babraham Research Campus
  • Cambridge CB22 3AT
  • England, United Kingdom
Primary Industry
Other Commercial Services
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • Babraham Research Campus
  • Cambridge CB22 3AT
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Antitope Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Antitope‘s full profile, request access.

Request a free trial

Antitope Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Antitope FAQs

  • When was Antitope founded?

    Antitope was founded in 2004.

  • Where is Antitope headquartered?

    Antitope is headquartered in Cambridge, United Kingdom.

  • What is the size of Antitope?

    Antitope has 121 total employees.

  • What industry is Antitope in?

    Antitope’s primary industry is Other Commercial Services.

  • Is Antitope a private or public company?

    Antitope is a Private company.

  • What is Antitope’s current revenue?

    The current revenue for Antitope is .

  • When was Antitope acquired?

    Antitope was acquired on 01-Jan-2016.

  • Who acquired Antitope?

    Antitope was acquired by Abzena.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process